Sun Pharmaceutical Industries Limited reported an inspiring 286.1% surge in net profit to Rs 1,241.1 crore for the Q3FY 2018-19 The Company, in the same period last year, had posted a net profit of Rs 321.5 crore. Operational revenues rose 17%in the Oct-Dec 2018 quarter to Rs 7,933.25 crore in comparison with Rs6782.42 crore. The EBITDA for the quarter under review was at Rs2151 crore. The EBITDA margin was at 27.8 percent.

Shares of Sun pharma closed higher at Rs. 442.45 up by 3.24% in the weak market breadth, Tuesday.